The Population Health Colorectal Cancer Screening Program is a collaborative effort between Fred Hutch and UW Medicine. Our goals are to eradicate colorectal cancer by improving screening, reducing racial, ethnic, and socioeconomic disparities, and improving follow-up for those with abnormal non-invasive screening tests. We do this through quality improvement, research, community engagement, and informing local and national health policy.
By using mailed stool-based colorectal cancer screening tests (fecal immunochemical test - FIT), our team is improving access to colorectal cancer prevention.
Our research focuses on the early detection and prevention of colorectal cancer through increased screening, especially among medically underserved populations. Our current projects include evaluations of novel interventions to increase adherence to colorectal cancer screening and follow-up of abnormal results.
Dr. Rachel Issaka receives the Kathryn Surace-Smith Endowed Chair in Health Equity Research
Flexible funding will further physician-scientist’s work in colorectal cancer and health inequities
Fred Hutch News Service | Feb. 2, 2022
The COVID cancer effect
Oncologists are grappling with predicting—and mitigating—the effects of the pandemic
Scientific American | Dec. 1, 2021
Which colon cancer screening is best?
Colon cancer screening can save lives. There are several types of screening options, but any screening is better than none.
U.S. News & World Report | Aug. 27, 2021
Study ID’s major roadblocks to follow-up colon-cancer care
Lack of both transportation and interpreters can stall a clinic visit after an at-home test raises a red flag.
UW PostScript Blog | Aug. 10, 2021
Dr. Rachel Issaka, Program Director